Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Nuvectis Pharma (NVCT) Earnings Date, Estimates & Call Transcripts

Nuvectis Pharma logo
$10.30 -0.10 (-0.96%)
Closing price 04:00 PM Eastern
Extended Trading
$10.29 -0.01 (-0.10%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nuvectis Pharma Earnings Summary

Nuvectis Pharma announced Q1 2026 earnings on May 5, 2026, reporting an EPS of -$0.26, which topped the consensus estimate of -$0.30 by $0.04. With a trailing EPS of -$1.31, Nuvectis Pharma's earnings are expected to grow next year, from ($1.01) to ($0.98) per share.

Upcoming Q2
Earnings Date
Aug. 4Before Market OpensEstimated
Consensus EPS
(May. 5)
-$0.30
Actual EPS
(May. 5)
-$0.26 Beat By $0.04

Q1 2026 Earnings Resources

NVCT Upcoming Earnings

Nuvectis Pharma's next earnings date is estimated for Tuesday, August 4, 2026, based on past reporting schedules.

Get Nuvectis Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nuvectis Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

NVCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Nuvectis Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.29-$0.29-$0.29
Q2 20261-$0.25-$0.25-$0.25
Q3 20261-$0.26-$0.26-$0.26
Q4 20261-$0.28-$0.28-$0.28

Nuvectis Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/4/2026
(Estimated)
--------
5/5/2026Q1 2026-$0.30-$0.26+$0.04-$0.26--
2/11/2026Q4 2025-$0.26-$0.31 -$0.05-$0.31--
11/4/2025Q3 2025-$0.24-$0.44 -$0.20-$0.44--
8/5/2025Q2 2025-$0.25-$0.30 -$0.05-$0.30--
5/6/2025Q1 2025-$0.30-$0.27+$0.03-$0.27--
3/4/2025Q4 2024-$0.28-$0.36 -$0.08-$0.36--
11/5/2024Q3 2024-$0.25-$0.24+$0.01-$0.24--
8/6/2024Q2 2024-$0.26-$0.26--$0.26--

Data powered by Fiscal.ai.

Nuvectis Pharma Earnings - Frequently Asked Questions

Nuvectis Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 4th, 2026 based off last year's report dates. Learn more on NVCT's earnings history.

In the previous quarter, Nuvectis Pharma (NASDAQ:NVCT) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.04. Learn more on analysts' earnings estimate vs. NVCT's actual earnings.

Nuvectis Pharma (NASDAQ:NVCT) has a recorded net income of -$26.44 million. NVCT has generated -$1.31 earnings per share over the last four quarters.

Nuvectis Pharma's earnings are expected to grow from ($1.01) per share to ($0.98) per share in the next year.


This page (NASDAQ:NVCT) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners